Killer immune cells that halt malaria could hold key to new vaccines

June 26, 2018, eLife
Credit: CC0 Public Domain

Scientists have revealed that immune cells called natural killer (NK) cells may play a key role in ridding the body of malaria-infected blood cells, a study in eLife reports.

The discovery adds to knowledge of how natural immunity to develops in people living in areas where the parasite is common, and provides a new mechanism that could be exploited in the mission to create a malaria vaccine.

"One of the main objectives in malaria research is to define the mechanisms by which naturally acquired antibodies provide protection," says lead author Gunjan Arora, Postdoctoral Fellow at the National Institute of Allergy and Infectious Diseases (NIAID), US. "We know that NK cells kill virus-infected cells and cancer cells, but a clear role for them in contributing to protection from malaria is yet to be established. We wanted to investigate the effects of human NK cells on malaria-infected in the presence of different human antibodies."

They started by isolating NK cells from people in the US who had never been exposed to malaria and looking at the effects on malaria-infected in the presence of different antibodies. When incubated with antibodies from people in Mali, who have a degree of natural immunity to malaria, the NK cells became active and produced immune-stimulating molecules.

Natural killer cells (green) destroy parasite-infected red blood cells (red) if antibodies from adults who live in a malaria-endemic region are included. Uninfected red blood cells (blue) are spared. Credit: Gunjan Arora and Javier Manzella-Lapeira

Next, the team looked at whether NK cells could kill infected red cells without damaging uninfected ones. They labelled NK cells, along with infected and uninfected red blood cells, and incubated them together with different antibodies. In the presence of the Mali antibodies, but not those from people in the US, the NK cells killed the infected red blood cells but left uninfected cells intact.

This led the scientists to investigate whether NK cells could also halt the growth of malaria within red blood cells. They allowed the parasites within red blood cells to go through one cycle of growth, and then counted the resulting number of newly infected cells. In the absence of antibodies, or with antibodies isolated from people in the US, NK cells blocked malaria growth by around 4-6%. When incubated with antibodies from people in Mali, the NK cells blocked growth by more than 60%. This showed that antibody-activated NK cells can stop malaria parasites from maturing into a form that can go on to infect other blood cells.

Antibodies from people living in the US do not stimulate natural killer cells (green) to kill parasite-infected red blood cells (red). Credit: Gunjan Arora and Javier Manzella-Lapeira

Finally, the team wanted to find the mechanism behind this antibody-driven attack by NK cells. Blood cells infected with malaria have molecules on their surface that antibodies recognize and use to attract immune cells. The team identified a molecule that was essential for activation of NK cells in response to malaria-infected blood cells. Although PfEMP1 was already known to be important in antibody recognition of malaria-infected cells, this study showed for the first time that it is crucial for activating NK cells in a manner dependent on antibodies.

"Considering the essential role of antibodies in granting clinical immunity to people living in areas of high malaria transmission, and the limited effectiveness of malaria vaccines tested so far, any immune responses that depend on warrant further investigation," says senior author Eric Long, Senior Investigator at NIAID. "Our discovery of antibody-mediated killing of malaria-infected blood cells by NK adds an additional immune mechanism to those already known."

Explore further: New understanding of the way chikungunya virus protects mice against malaria could lead to improved patient care

More information: Gunjan Arora et al, NK cells inhibit Plasmodium falciparum growth in red blood cells via antibody-dependent cellular cytotoxicity, eLife (2018). DOI: 10.7554/eLife.36806

Related Stories

Malaria: Cooperating antibodies enhance immune response

June 7, 2018

Malaria is one of the most infectious diseases worldwide. Scientists from the German Cancer Research Center (DKFZ) in Heidelberg, Germany, and from the Hospital for Sick Children (SickKids) in Toronto, Canada, have studied ...

Improving human immunity to malaria

August 1, 2012

The deadliest form of malaria is caused the protozoan Plasmodium falciparum. During its life-cycle in human blood, the parasite P. falciparum expresses unique proteins on the surface on infected blood cells.

Human antibodies undermine parasite sex

February 8, 2018

Some people develop an immune response following a malaria infection that stops them from infecting other mosquitoes. The antibodies that these people produce are ingested by the mosquito and destroy the malaria parasite ...

Recommended for you

Coffee-based colloids for direct solar absorption

March 22, 2019

Solar energy is one of the most promising resources to help reduce fossil fuel consumption and mitigate greenhouse gas emissions to power a sustainable future. Devices presently in use to convert solar energy into thermal ...

EPA adviser is promoting harmful ideas, scientists say

March 22, 2019

The Trump administration's reliance on industry-funded environmental specialists is again coming under fire, this time by researchers who say that Louis Anthony "Tony" Cox Jr., who leads a key Environmental Protection Agency ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.